Nathalie Brun
Keine laufenden Positionen mehr
Karriereverlauf von Nathalie Brun
Ehemalige bekannte Positionen von Nathalie Brun
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELSALYS BIOTECH | Finanzdirektor/CFO | 01.07.2017 | 01.09.2019 |
Axxès SAS
Axxès SAS Other TransportationTransportation Axxès SAS provides toll and parking fee collection services. The company is headquartered in Lyon, France. | Verwaltungsdirektor | 01.07.2005 | 01.12.2007 |
Finanzdirektor/CFO | 01.07.2005 | 01.12.2007 | |
AKKA TECHNOLOGIES SE | Verwaltungsdirektor | 01.01.1996 | 01.04.2001 |
Finanzdirektor/CFO | 01.01.1996 | 01.04.2001 |
Ausbildung von Nathalie Brun
EM Lyon Business School | Graduate Degree |
Statistik
International
Frankreich | 4 |
Belgien | 2 |
Operativ
Director of Finance/CFO | 3 |
Chief Administrative Officer | 2 |
Graduate Degree | 1 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Transportation | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
AKKA Technologies SE
AKKA Technologies SE Miscellaneous Commercial ServicesCommercial Services AKKA Technologies SE engages in the provision of engineering consulting and research and development services in the mobility sector. It operates through the following geographical segments: France, Germany, North America, International, Data Respons, and Other. The firm offers software engineering, systems engineering, and mechanical and thermal engineering solutions. The company was founded by Maurice Ricci on April 1, 1984 and is headquartered in Brussels, Belgium. | Commercial Services |
Axxès SAS
Axxès SAS Other TransportationTransportation Axxès SAS provides toll and parking fee collection services. The company is headquartered in Lyon, France. | Transportation |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Börse
- Insiders
- Nathalie Brun
- Erfahrung